Impax Laboratories to Present at the Piper Jaffray 24th Annual Healthcare Conference

  Impax Laboratories to Present at the Piper Jaffray 24th Annual Healthcare
  Conference

Piper Jaffray Healthcare Conference 2012

Business Wire

HAYWARD, Calif. -- November 20, 2012

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will
present at the Piper Jaffray 24^th Annual Healthcare Conference on Tuesday,
November 27, at 8:00 a.m. Eastern Standard Time. The conference will be held
at the New York Palace Hotel located in New York.

Individuals may listen to the live or an archived presentation made at the
conference, which will be posted in the investor relations section of the
Company’s web site at www.impaxlabs.com. This presentation will be archived on
the Company’s web site for 30 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. (“Impax”) is a technology based specialty
pharmaceutical company applying its formulation expertise and drug delivery
technology to the development of controlled-release and specialty generics in
addition to the development of branded products. Impax markets its generic
products through its Global Pharmaceuticals division and markets its branded
products through the Impax Pharmaceuticals division. Additionally, where
strategically appropriate, Impax has developed marketing partnerships to fully
leverage its technology platform. Impax is headquartered in Hayward,
California, and has a full range of capabilities in its Hayward, Philadelphia
and Taiwan facilities. For more information, please visit the Company's Web
site at: www.impaxlabs.com.

Contact:

Impax Laboratories, Inc.
Mark Donohue
Sr. Director, Investor Relations and Corporate Communications
215-558-4526
www.impaxlabs.com
 
Press spacebar to pause and continue. Press esc to stop.